رفرنس استاندارد کلاریترومایسین ناخالصی A Clarithromycin Related Compound A (25 mg) 1134380 USP

لینک کالا در سایت سیگما ( کلیک کنید )

لینک کالا در سایت USP ( کلیک کنید )

برگه انالیز کالا ( کلیک کنید )

Clarithromycin Related Compound A (25 mg) (6,11-di-O-methylerythromycin A)

Catalog No:

1134380

CAS RN®

81103-14-2

Molecular Formula:

C39H71NO13

Product Type:

Reference Standard

Related Products

remove quantity box add

Add to Cart

star Add to Favorites

Shipping Information

Current Lot Information

• Current Lot: R114R0

• CAS RN® 81103-14-2

• Harmonized System (HS) Code *: 293220

• UN No: N/A

• NDC No: N/A

• Molecular Formula: C39H71NO13

• Container Type: VIAL

• Base Control Substance (substance %): N/A

1134380

USP

Share

Clarithromycin Related Compound A

No rating value Same page link.

(0)

Write a review

Ask a question

United States Pharmacopeia (USP) Reference Standard

Sign Into View Organizational & Contract Pricing

Select a Size

Change View

25 MG

€1,240.00

Synonym(s):

6,11-Di-O-methylerythromycin A

Empirical Formula (Hill Notation):

C39H71NO13

CAS Number:

81103-14-2

Molecular Weight:

761.98

MDL number:

MFCD26142870

UNSPSC Code:

41116107

PubChem Substance ID:

329749412

NACRES:

NA.24

Properties

grade

pharmaceutical primary standard

API family

clarithromycin

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

O=C1O[C@H](CC)[C@@](C)(O)[C@H](OC)[C@@H](C)C([C@H](C)C[C@@](C)(OC)[C@H](O[C@H]2[C@H](O)[C@@H](N(C)C)C[C@@H](C)O2)[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@H]1C)=O

InChI

1S/C39H71NO13/c1-16-27-39(10,45)34(46-13)22(4)29(41)20(2)18-38(9,48-15)33(53-36-30(42)26(40(11)12)17-21(3)49-36)23(5)31(24(6)35(44)51-27)52-28-19-37(8,47-14)32(43)25(7)50-28/h20-28,30-34,36,42-43,45H,16-19H2,1-15H3/t20-,21-,22+,23+,24-,25+,26+,27-,28+,30-,31+,32+,33-,34-,36+,37-,38-,39-/m1/s1

InChI key

DWRKNXHSSDFLOJ-XNLUWZQGSA-N

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

• 
  

• Ecotoxicity analysis of clarithromycin: Research examined the effects of environmental factors like pH and dissolved organic carbon on the ecotoxicity of pharmaceuticals including clarithromycin, providing insights into environmental impact and informing guidelines for the disposal and management of antibiotic waste in the pharmaceutical industry (Zhang et al., 2023).

• 
  

• Pharmacological potential of natural compounds against H. pylori: An in vitro and in silico study evaluated the anti-Helicobacter pylori and anti-inflammatory potentials of Salvia officinalis metabolites, considering the role of clarithromycin as a comparative standard. This research contributes to the exploration of alternative therapies in gastroenterological pharmaceutical applications (Alomar et al., 2023).

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.